
Founded in 1993, IDG Capital is a leading private equity investment firm headquartered in Hong Kong, recognized for its global vision and long-standing market presence. Over the past three decades, we have built a truly global investment platform with strong connectivity across key markets. Our seasoned team combines first-hand market insight with a global perspective, leveraging an extensive network of industry resources and strategic partners. We invest across consumer technology, healthcare, and consumer sectors, partnering with exceptional companies throughout their growth journey and supporting their international expansion.
此公司進入各市場的次序 — 由最舊至最新
Managing Director
註冊以查看完整訊號動態
IDG Capital 的國際擴張與競爭對手的比較
長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
IDG Capital你 | 0 | 0 | 0% | 0 | 32 |
無進行中的廣告活動
註冊以追蹤此公司,並在發生變化時第一時間獲得提醒。
METiS TechBio,一家AI驅動的藥物遞送公司,成功在港交所上市,籌集超過21億港元,獲18家基石投資者包括貝萊德支持。
CBInsights評估瑞波幣公司價值150億美元,全球排名第23。XRP在市場停滯中顯示復甦跡象,技術指標暗示可能上行動力。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 IDG Capital 業務、市場及增長訊號的快速解答。
